Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic therapy (DMARD).

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2599

Title:	Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic therapy (DMARD).
Authors:	Gamero, P Landewe, RBM Boers, M Christgau, S van der Linden, SJ VAN DER HEIJDE, Desiree GEUSENS, Piet
Issue Date:	2002
Publisher:	WILEY-LISS
Source:	ARTHRITIS AND RHEUMATISM, 46(9). p. S376-S376
Notes:	Synarc, INSERM, Unit 403, Lyon, France. Univ Hosp Maastricht, Maastricht, Netherlands. Nord Biosci Diagnost, Herlev, Denmark. Willems Inst, Diepenbeek, Belgium.
Document URI:	http://hdl.handle.net/1942/2599
ISSN:	0004-3591
ISI #:	000178421801004
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

Check